Pulse
Pulse builds conversational AI for healthcare and life sciences companies, including large pharmaceutical enterprises like Novartis and Sanofi. Scratch, built for We CU and Novartis, is a 24/7 chatbot for chronic urticaria patients. It lives on chronic-urticaria.org and draws on 170+ published medical articles to help patients, caregivers, and families learn about their condition and connect with the We CU community. Pulmo, built for GAAPP and Novartis, is an asthma education assistant that helps users understand triggers, symptoms, treatment categories, and how to prepare for doctor visits, with clear guardrails that keep it scoped to education only. Asthma Care Map 2.0, a collaboration between Sanofi, GAAPP, AAFA, EFA, EUFOREA, and SMILE SMILE, goes beyond Q&A. The bot sits on 8,000+ medically-endorsed proof points filtered by region and generates tailored advocacy reports as PDF and PPT outputs for policymakers and politicians. Pulse treats chatbots as workflow engines, not search layers. Education flows guide patients through condition learning and treatment exploration. Operations flows move tasks like re-ordering, scheduling, and care updates into a chat interface. Internal bots handle PII-sensitive backend workflows like intake routing and insurance verification with full access controls and audit trails. Every Pulse chatbot is built with strict scope boundaries. Bots don't guess, improvise, or engage outside their defined function. Pulse bots say "I don't know" rather than hallucinate, and redirect out-of-scope conversations rather than risk an organization unintentionally taking a position through its AI. Pulse builds with HIPAA-compliant architecture, data residency considerations for global deployments, and the content review workflows large pharmaceutical enterprises require. Every bot ships through clinical and legal review with the client's compliance team. Pulse handles strategy, conversation design, medical content structuring, Botpress implementation, and ongoing optimization. For healthcare companies evaluating Botpress, Pulse already knows the platform, the regulatory environment in the US and EU, and what it takes to get a medical chatbot to production.